|
|
Key Issues to be Discussed Including:
- Cancer Screening, Detection, Control and Prevention
- Best Clinical Practice
- Cancer Hospital Management
- Breaking Cancer Research toward Next Decade
- Cancer Economic Forum-Business, Funding, Finance and Investment
- Targeted Immunotherapy for Cancers
- How to Address the Challenge of Scientific Innovation
- Treatment of Metastases with Unknown Primary
- The Cancer Targeting Gene-Viro-Therapy Strategy with Complete Eradication of Xenograft Tumors
Want to hear these topics? Register now!
Share your view on these issues
|
Why You Should Attend in 2014?
- Seize the unique opportunity to network with the leading executives
- Participate in workshops on the latest strategies, share best practices with your market peers
- Discuss all the pressing issues other industry expert
- Access a comprehensive overview and debate how it can be improved
- Establish partnerships with the most important solution providers doing – or planning to do – business in the region
Don't Just Take Our Word for It:
- “Very well designed. Very impressed with the choice of speakers. Very impressive conference with very interesting insights.”
- Greg Adams, Co-Leader, Development Therapeutics Program, Fox Chase Cancer Center.
- “This is always a ‘must attend’ for people involved in the design, development and evaluation of therapeutic antibodies. There are many potential contacts to boost your collaborations and your projects.”
- Andre Pelegrin, Director, IRCM, France.
- “Very good experience at the event. The networking is very good. I got contacts of people my company may do business with”
- Prof.Patrick Baeuerle, Senior Vice President, Chief Scientific Officer, Micromet
Who You Will Meet:
INDUSTRY
|
GEOGRAPHY
|
JOB TITLE
 |
|
|
|
|
